Guillermo Abesada‐Terk
- Virology top 5%
- Immunology top 10%
-
- Global Cancer Incidence and Screening 3
- Cancer survivorship and care 3
- Colorectal Cancer Screening and Detection 2
-
- Economic and Financial Impacts of Cancer 4
-
- Lung Cancer Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
-
- Breast Cancer Treatment Studies 2
-
- Nausea and vomiting management 1
- Co-authors
- Ari D. BrooksMatthieu PerreauJeffrey M. JacobsonJacob D. EstesElias K. HaddadAmie L. MeditzTalibah MetcalfGordon J. Freeman
- Cited by
- VirologyImmunologyOncology
- Journals
- Nature Medicine (1 paper)Journal of Clinical Oncology (1 paper)Journal of the American College of Surgeons (2 papers)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Guillermo Abesada‐Terk
12 papers receiving 551 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Virology 146
- Immunology 253
- Oncology 201
- Hematology 29
- Public Health, Environmental and Occupational Health 75
Countries citing papers authored by Guillermo Abesada‐Terk
This map shows the geographic impact of Guillermo Abesada‐Terk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Abesada‐Terk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Abesada‐Terk more than expected).
Fields of papers citing papers by Guillermo Abesada‐Terk
This network shows the impact of papers produced by Guillermo Abesada‐Terk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Abesada‐Terk. The network helps show where Guillermo Abesada‐Terk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guillermo Abesada‐Terk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).breakdown → | 2022 | 125 |
| 2 | 2015 | 4 | |
| 3 | 2015 | 6 | |
| 4 | 2014 | 12 | |
| 5 | 2014 | 11 | |
| 6 | 2013 | 20 | |
| 7 | 2013 | 287 | |
| 8 | 2012 | 10 | |
| 9 | 2011 | 10 | |
| 10 | 2011 | 16 | |
| 11 | 2010 | 47 | |
| 12 | 2009 | 14 |
About Guillermo Abesada‐Terk
Guillermo Abesada‐Terk is a scholar working on Oncology, Virology and Anesthesiology and Pain Medicine, having authored 12 papers that have together received 562 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (4 papers), Global Cancer Incidence and Screening (3 papers), Cancer survivorship and care (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Breast Cancer Treatment Studies (2 papers), Colorectal Cancer Screening and Detection (2 papers) and Nausea and vomiting management (1 paper). The work is most often cited by research in Virology (146 citations), Immunology (253 citations) and Oncology (201 citations). Guillermo Abesada‐Terk has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Ari D. Brooks, Matthieu Perreau, Jeffrey M. Jacobson, Jacob D. Estes, Elias K. Haddad, Amie L. Meditz, Talibah Metcalf, Gordon J. Freeman, Shane Crotty and Rafael Cubas. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Journal of the American College of Surgeons.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.